Publication | Closed Access

A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery

NanomedicineMedicinal ChemistryDrug TargetingPolymer-drug ConjugateMedicineTumor-targeted Drug DeliveryDrug Delivery SystemsNano-drug DeliveryTumor TargetingPh-sensitive Doxorubicin ProdrugAnti-cancer AgentPharmacologyRadiation OncologyFolate-conjugated Bsa